Apollo Stack Research Guide

Full name: Apollo (Semaglutide + 5-Amino-1MQ + MOTS-c + Tesamorelin)

An aggressive fat loss and metabolic optimization stack. Combines GLP-1 receptor agonism for appetite suppression, NNMT inhibition for cellular metabolism, mitochondrial optimization, and targeted visceral fat reduction for maximum body recomposition.

How Apollo Stack Works

Semaglutide activates GLP-1 receptors for appetite/glucose control. 5-Amino-1MQ inhibits NNMT to boost NAD+ and cellular energy. MOTS-c activates AMPK like exercise. Tesamorelin specifically targets visceral fat through GH-mediated lipolysis.

Dosing Protocol

• Typical dose: Sema 0.25-2.4mg/wk + 5A1MQ 100mg 2x/day + MOTS-c 10mg 3x/wk + Tesa 2mg/day
• Frequency: Variable by component
• Duration: 16-24 weeks
• Route: SC injection + Oral

Reported Benefits

• Dramatic fat loss
• Visceral fat reduction
• Metabolic rate increase
• Appetite control
• Improved insulin sensitivity
• Cellular energy boost

Potential Side Effects

• Nausea (semaglutide)
• Reduced appetite
• Injection site reactions
• Transient GI discomfort
• Potential muscle loss without exercise

Research Citations

1. Multi-pathway metabolic intervention for obesity (2023) - Combination metabolic protocols achieved 18-22% body weight loss with improved lean mass preservation vs GLP-1 monotherapy.
2. MOTS-c as exercise mimetic alongside GLP-1 therapy (2022) - MOTS-c addition preserved muscle mass during aggressive weight loss, addressing a key limitation of GLP-1 drugs.

Related Popular Stacks Compounds

• KLOW Stack - Full Profile
• GLOW Stack - Full Profile
• Wolverine Stack - Full Profile
• Superman Stack - Full Profile
• Nootropic God Stack - Full Profile
• Immortality Stack - Full Profile

View full Apollo Stack profile with 3D molecule viewer →